Atlas Trials

Changing the coUrse of cRohn's Disease With an Early Use of Adalimumab

Clinical trial NCT03306446 · UNKNOWN

Trial details

NCT number
NCT03306446
Sponsor
Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
CD
Start date
2015-03-17
Primary completion
2021-03-01
Enrollment
203

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.